Patents Assigned to GINKGO PHARAMA CO., LTD.
  • Macrocyclic compounds for suppressing replication of hepatitis C virus
    Patent number: 9321809
    Abstract: A compound as represented by Formula (I) is provided, wherein groups are defined in the description. The compound is used as HCV protease inhibitor for treating HCV infection.
    Type: Grant
    Filed: December 5, 2012
    Date of Patent: April 26, 2016
    Assignee: GINKGO PHARAMA CO., LTD.
    Inventors: Ben Li, Li Chen, Peibing Zhai, Tao Jiang